Market Tracker

07/28 2:23pm ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

5.85
BATS BZX Real-Time Price
As of 2:22pm ET
 -0.21 / -3.47%
Today’s Change
3.61
Today|||52-Week Range
11.15
-4.57%
Year-to-Date
3 Cheap Healthcare Stocks You Can Buy Right Now
Jul 21 / MotleyFool.com - Paid Partner Content
Why Progenics Pharmaceuticals, Inc. Shares Soared Today
Jul 20 / MotleyFool.com - Paid Partner Content
Progenics Pharmaceuticals (PGNX) Is Today's Perilous Reversal Stock
Jul 21 / TheStreet.com - Paid Partner Content
Valeant/Progenics Relistor Ok'd; FDA Panel Backs Brodalumab
Jul 20 / Zacks.com - Paid Partner Content
4 Small-Cap Biotechs With Big Stories to Tell
Jul 21 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close6.06
Today’s open6.06
Day’s range5.76 - 6.16
Volume161,377
Average volume (3 months)1,215,906
Market cap$423.9M
Dividend yield--
Data as of 2:22pm ET, 07/28/2016

Growth & Valuation

Earnings growth (last year)-1,033.33%
Earnings growth (this year)+117.41%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-80.45%
P/E ratioNM
Price/Sales49.26
Price/Book4.69

Competitors

 Today’s
change
Today’s
% change
ARNAArena Pharmaceutical...-0.04-2.34%
ACRSAclaris Therapeutics...-0.06-0.29%
ENTAEnanta Pharmaceutica...-0.51-2.35%
OMEROmeros Corp+0.46+4.11%
Data as of 2:21pm ET, 07/28/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$8.7M
Annual profit (last year)-$39.1M
Net profit margin-450.81%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark Robert Baker
Head-
Operations
Meryl J. Longval
Corporate headquarters
Tarrytown, New York

Forecasts